Science Explorer Back to mapMap

Most cited papers from SiteOne Therapeutics (United States)

What are the most cited papers from SiteOne Therapeutics (United States)?

The most cited paper from SiteOne Therapeutics (United States) is "Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na V 1.7" (John V. Mulcahy, Hassan Pajouhesh, Jacob T. Beckley et al., 2019), with 101 citations. Next come "1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia" (72) and "Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins" (44).

Showing 23 of 23 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na V 1.7 John V. Mulcahy, Hassan Pajouhesh, Jacob T. Beckley et al. · Journal of Medicinal Chemistry Open access 23 Apr 2019 101
2 1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia Sampath‐Kumar Anandan et al. · Bioorganic & Medicinal Chemistry Letters Open access 14 Dec 2010 72
3 Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins Hassan Pajouhesh, Jacob T. Beckley, Anton Delwig et al. · Scientific Reports Open access 9 Sep 2020 44
4 Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain Jacob T. Beckley, Hassan Pajouhesh, George Luu et al. · Pain Open access 15 Oct 2020 36
5 Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N′-diaryl urea inhibitors of soluble epoxide hydrolase Sampath‐Kumar Anandan, Richard D. Gless · Bioorganic & Medicinal Chemistry Letters Open access 23 Mar 2010 23
6 Hair Methylmercury Levels in U.S. Women Jeremy C. Smith, Paul V. Allen, Rudy Von Burg · Archives of Environmental Health An International Journal Nov 1997 22
7 Effectiveness of endovenous laser treatment in eliminating superficial venous reflux Frederick A Elmore, Donald A. Lackey · Phlebology The Journal of Venous Disease Feb 2008 21
8 DISEASES OF FOALS A. Murray Bain · Australian Veterinary Journal 1954 21
9 ST‐2560, a selective inhibitor of the NaV1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non‐human primates John V. Mulcahy, Jacob T. Beckley, Sheri Klas et al. · British Journal of Pharmacology Open access 7 May 2024 18
10 Discovery of Selective Inhibitors of NaV1.7 Templated on Saxitoxin as Therapeutics for Pain Hassan Pajouhesh, Anton Delwig, Jacob T. Beckley et al. · ACS Medicinal Chemistry Letters Open access 18 Oct 2022 11
11 Role of NaV1.7 in action potential conduction along human bronchial vagal afferent C‐fibres Marián Kollárik, Fei Ru, Nikoleta Pavelková et al. · British Journal of Pharmacology Open access 11 Oct 2021 9
12 Zero Breast Implant Infection Rate and 0.05% Hematoma Rate Following 1720 Silicone Implant Placements for Primary Breast Augmentation: Surgical Technique or Surgeon Luck? Evangelos Keramidas · Aesthetic Plastic Surgery 21 Nov 2008 9
13 Topical Valganciclovir for the Treatment of Hypertensive Anterior Uveitis Anton Delwig, Jeremy David Keenan, Todd P. Margolis · Cornea 11 Sep 2015 5
14 Informative Correlations among Metrics of Yellowstone Lake Cutthroat Trout Caught by Two Quantitative Methods across Three Recent Decades Lynn R. Kaeding · North American Journal of Fisheries Management 13 Aug 2013 3
15 A single MHCII neoepitope mRNA vaccine elicits CD4 T- and B- cell responses promoting endogenous CD8 anti-tumor immunity Aude-Hélène Capietto et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 12 Jun 2025 2
16 Congenital Insensitivity to Pain: A Case Report With Corneal Esthesiometry and In Vivo Confocal Microscopy Jeremy David Keenan, John A. Gonzales, Stephen G. Waxman et al. · Cornea 20 Jan 2021 2
17 Evaluation of Selective NaV1.7 Inhibitors for the Treatment of Ocular Pain Anton Delwig, Hassan Pajouhesh, David C. Yeomans et al. · Investigative Ophthalmology & Visual Science Open access 13 Jul 2018 1
18 Addendum to: Elmore FA and Lackey D. Effectiveness of endovenous laser treatment in eliminating superficial venous reflux.Phlebology 2008;23:21–31, DOI: 10.1258/phleb.2007.007019 Frederick A Elmore · Phlebology The Journal of Venous Disease 29 Mar 2008 1
19 BACTEROEDES ARTHRITIS IN A FOAL A. Murray Bain, K. G. Johnston · Australian Veterinary Journal Aug 1955 1
20 An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters Ryan A. Altman, Annalaura Brai, Jennifer E. Golden et al. · ACS Medicinal Chemistry Letters Open access 3 Feb 2022 0
21 NaV1.7 inhibitors relieve ocular discomfort in a rat model of dry eye disease Anton Delwig, Chaojie Liu, Ian D. Meng et al. · Investigative Ophthalmology & Visual Science Open access 10 Jun 2020 0
22 Antinociceptive sodium channel inhibitors having extended duration of action John V. Mulcahy, Deepak Behera, Brian D. Andresen et al. · Journal of Pain Open access Apr 2011 0
23 35. Development of Guanidinium-Toxin-Based Sodium Channel Blockers as PET Imaging Agents and Therapeutics for Diagnosing and Treating Pain John V. Mulcahy, Justin Du Bois, David C. Yeomans et al. · Toxicon 2 Jun 2012 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.